Projects per year
Personal profile
Diplomas
Areas of expertise
Awards
Alfers Prize 2022
Namurois de l'année 2019
Eberhard F. Mammen - Young Investigator Award 2019
Prix Léo Pharma 2017 - Cancer et Thrombose
XXIV Congress of the International Society on Thrombosis and Haemostasis - Young Investigator Award
58th Annual SSC Meeting of the International Society on Thrombosis and Haemostasis - Young Investigator Award
55th American Society of Hematology Annual Meeting and Exposition - Abstract Achievement Award
56th American Society of Hematology Annual Meeting and Exposition - Abstract Achievement Award
External responsibilities
CEO of QUALIblood sa
Co-Chairman of the SSC Control of Anticoagulation of the Interntional Society on Thrombosis and Hemostasis
Pharmacovigilance Expert at the Federal Agency of Medicines and Health Products
Member of Expert Team Haemostasis Diagnostics at the ECAT Foundation
Member of the Expert Committee of the Assemblée Scientifique des Pharmaciens Francophones
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
Doctor of Pharmacy, University of Namur
Award Date: 24 Oct 2015
Master of Pharmacy, Université Catholique de Louvain
Award Date: 24 Jun 2011
Bachelor of Pharmacy, University of Namur
Award Date: 4 Sept 2009
External positions
Member of the Expert Team Haemostasis Diagnostics, ECAT Foundation
Nov 2019 → …
Chief Executive Officer, Qualiblood
Nov 2017 → …
Co-Chairman, International Society on Thrombosis and Haemostasis
Nov 2016 → …
Fingerprint
Dive into the research topics where Jonathan Douxfils is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
NucleoGlio (BioWin): Development of a diagnostic test for glioblastoma and follow-up of patients
Douxfils, J. (PI)
1/11/23 → 31/10/27
Project: Research
-
PALPITATION: The platelet lipidome, a promising diagnostic or therapeutic option for HFpEF patients
Horman, S. (PI), POULEUR, A.-C. (CoPI), Dessy, C. (CoPI) & Douxfils, J. (CoPI)
1/10/23 → 30/09/28
Project: Research
-
Management of (activated) factor eleven (FXI(a)) inhibitors
Vassart, J. (Researcher), Douxfils, J. (PI) & Dogne, J.-M. (Co-supervisor)
17/10/22 → …
Project: PHD
-
Clinical Pharmacology Research Group
Douxfils, J. (Supervisor), Dogne, J.-M. (Supervisor), Musuamba Tshinanu, F. (Supervisor), Masereel, B. (Supervisor), Wieërs, G. (Supervisor), Haguet, H. (Researcher), RONVAUX, L. (Researcher), Donis, N. (Researcher), Morimont, L. (Researcher), Evrard, J. (Researcher), Siriez, R. (Researcher), Gillot, C. (Researcher), FAVRESSE, J. (Researcher), BOUVY, C. (Researcher), Djokoto, H. (Researcher), Didembourg, M. (Researcher), David, C. (Support role), Melchionda, S. (Support role), Maloteau, V. (Technician), Boucher, A.-Y. (Technician), Devel, P. (Technician), Modaffari, E. (Technician), Vandeputte, M. (Technician), De Messemaeker, A. (Secretaire), Decarpentrie, J. (Researcher), Vassart, J. (Researcher) & De Groote, A. (Researcher)
1/04/22 → …
Project: Research Axis
-
Accuracy of DOAC Dipstick urine test from patients treated peri-operatively with DOACs compared to UHPLC-MS/MS
Vassart, J., Boucher, A.-Y., Morimont, L., Tafur, A., Walenga, J., Harenberg, J. F. & Douxfils, J., 27 Feb 2024.Research output: Contribution to conference › Poster › peer-review
File7 Downloads (Pure) -
A comparative in vitro study of the anticoagulant effect of branded versus generic rivaroxaban
Mangion, K., Vella, K., Gatt, A., Vella, A. M., Borg, M., Borg-Aquilina, D., Douxfils, J., Camilleri, L. & Riva, N., Mar 2024, In: Thrombosis Research. 235, p. 41-51 11 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Algorithm for Rapid Exclusion of Clinically Relevant Plasma Levels of Direct Oral Anticoagulants in Patients Using the DOAC Dipstick: An expert consensus paper
Harenberg, J., Gosselin, R. C., Cuker, A., Becattini, C., Pabinger, I., Poli, S., Weitz, J. I., Ageno, W., Bauersachs, R., Ćelap, I., Choi, P., Douketis, J., Douxfils, J., Elalamy, I., Fareed, J., Falanga, A., Favalor, E., Gerotziafas, G. T., Herkner, H. & Hetjens, S. & 17 others, , 5 Feb 2024, (E-pub ahead of print) In: Thrombosis and Haemostasis.Research output: Contribution to journal › Article › peer-review
Open AccessFile31 Downloads (Pure) -
An Evaluation of a SARS-CoV-2 Pseudovirus Neutralization Test and A Comparison to a SARS-CoV-2 Surrogate Virus Neutralization Test in a COVID-19 Long-Term Follow-Up Cohort
Gillot, C., Favresse, J., David, C., Maloteau, V., Dogne, J. M. & Douxfils, J., 21 Mar 2024, In: Microbiology Research. 15, 1, p. 422-430 9 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile10 Downloads (Pure) -
Are natural estrogens used in contraception at lower risk of venous thromboembolism than synthetic ones? A systematic literature review and meta-analysis
Douxfils, J., Raskin, L., Didembourg, M., Donis, N., Dogné, J.-M., Morimont, L. & Beaudart, C., 2024, In: Frontiers in endocrinology. 15, p. 1428597 1428597.Research output: Contribution to journal › Article › peer-review
Open AccessFile12 Downloads (Pure)
Datasets
-
Risk of arterial and venous occlusive events in chronic myeloid leukemia patients treated with new generation BCR-ABL tyrosine kinase inhibitors: a systematic review and meta-analysis
Graux, C. (Contributor), Chatelain, C. (Contributor), Mullier, F. (Contributor), Haguet, H. (Contributor), DOGNE, J.-M. (Contributor) & Douxfils, J. (Contributor), Figshare, 29 Nov 2016
DOI: 10.6084/m9.figshare.4265168.v1, https://figshare.com/articles/Risk_of_arterial_and_venous_occlusive_events_in_chronic_myeloid_leukemia_patients_treated_with_new_generation_BCR-ABL_tyrosine_kinase_inhibitors_a_systematic_review_and_meta-analysis/4265168/1 and one more link, https://ndownloader.figshare.com/files/6948968 (show fewer)
Dataset
Prizes
-
55th ASH Annual Meeting and Exposition - Abstract Achievement Award
Douxfils, J. (Recipient), 7 Dec 2013
Prize: Prize (including medals and awards)
-
56th ASH Annual Meeting and Exposition - Abstract Achievement Award
Douxfils, J. (Recipient), 6 Dec 2014
Prize: Prize (including medals and awards)
-
58th Annual SSC Meeting of the ISTH - Young Investigators Awards
Douxfils, J. (Recipient), 26 Jun 2012
Prize: Prize (including medals and awards)
-
Alfers 2022 - Prix de l'innovation
Douxfils, J. (Recipient), 24 May 2022
Prize: Prize (including medals and awards)
-
Eberhard F. Mammen Young Investigator Award 2019
Douxfils, J. (Recipient), 2019
Prize: National/international honour
Activities
-
Innovative biomarkers in sepsis
Douxfils, J. (Speaker)
28 Mar 2024Activity: Talk or presentation types › Invited talk
-
Risque de thrombose associés aux contraceptifs hormonaux combinés - pourquoi l’évaluation de la résistance à la protéine C activée, appelée nAPCsr, est-elle importante?
Douxfils, J. (Speaker)
16 Mar 2024Activity: Talk or presentation types › Invited talk
-
Cardiovascular safety: the point of view of the veins
Douxfils, J. (Speaker)
8 Mar 2024Activity: Talk or presentation types › Invited talk
-
Risque de thrombose associés aux contraceptifs hormonaux combinés - pourquoi l’évaluation de la résistance à la protéine C activée, appelée nAPCsr, est-elle importante?
Douxfils, J. (Speaker)
22 Feb 2024Activity: Talk or presentation types › Invited talk
-
Rencontre Université de Namur - Faculté de Médecine et Clinique Saint-Luc de Bouge
Douxfils, J. (Contributor)
15 Feb 2024Activity: Participating in or organising an event types › Participation in workshop, seminar, course
Thesis
-
Evaluation of thrombotic and/or bleeding risks associated with anticoagulotherapy.
Douxfils, J. (Author)Dogne, J.-M. (Supervisor), Mullier, F. (Supervisor), Masereel, B. (President), Chatelain, B. (Jury), Chatelain, C. (Jury), Verhamme, P. (Jury), TEN CATE, H. (Jury) & Ageno, W. (Jury), 24 Oct 2015Student thesis: Doc types › Doctor of Biomedical and Pharmaceutical Sciences
-
Therapeutic monitoring of new oral anticoagulant: focus on dabigatran
Douxfils, J. (Author)Dogne, J.-M. (Supervisor), 2012Student thesis: Master types › Master in Pharmacy
Press/Media
-
FDA Warns of Liver Injury with Veozah for Hot Flashes
12/09/24
2 items of Media coverage
Press/Media: Expert Comment
-
FDA Warns of Liver Injury with Veozah for Hot Flashes
12/09/24
1 item of Media coverage
Press/Media: Expert Comment
-
University of Namur Researchers Detail New Studies and Findings in the Area of Vaccines [Vaccine-induced humoral response of BNT162b2 and mRNA-1273 against BA.1, BA.5, and XBB.1.5. (sub)variants 6 months after a homologous booster: is ...]
Dogne, J.-M., Douxfils, J., Tre-Hardy, M. & Gillot, C.
4/09/24
1 item of Media coverage
Press/Media: Expert Comment
-
FDA Warns of Liver Injury with Veozah for Hot Flashes
1/09/24
1 item of Media coverage
Press/Media: Expert Comment
-
Reports Outline COVID-19 Study Results from University of Namur (An Evaluation of a SARS-CoV-2 Pseudovirus Neutralization Test and A Comparison to a SARS-CoV-2 Surrogate Virus Neutralization Test in a COVID-19 Long-Term Follow-Up Cohort)
Dogne, J.-M., Douxfils, J. & Gillot, C.
5/04/24
1 item of Media coverage
Press/Media: Expert Comment